New Zealand markets close in 4 hours 40 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.49-0.04 (-0.30%)
At close: 04:00PM EST
13.49 0.00 (0.00%)
After hours: 05:43PM EST
Annual

Cash flow

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Cash flows from operating activities
Net income
473,105,000
376,005,000
44,241,000
109,126,000
186,886,000
Depreciation & amortisation
562,735,000
559,671,000
583,649,000
272,446,000
182,127,000
Deferred income taxes
51,796,000
-9,936,000
-105,044,000
-14,118,000
30,497,000
Stock-based compensation
40,537,000
37,663,000
29,122,000
20,084,000
18,610,000
Change in working capital
93,750,000
275,781,000
94,672,000
75,946,000
13,404,000
Accounts receivable
-
-
-
-
-647,000
Inventory
-1,997,000
25,978,000
137,492,000
58,678,000
13,719,000
Accounts payable
-
-
-
-
6,862,000
Other working capital
777,572,000
774,463,000
452,042,000
194,365,000
249,592,000
Other non-cash items
180,077,000
120,717,000
141,308,000
-12,867,000
23,717,000
Net cash provided by operating activities
1,018,931,000
1,010,931,000
669,752,000
328,479,000
377,854,000
Cash flows from investing activities
Investments in property, plant and equipment
-241,359,000
-236,468,000
-217,710,000
-134,114,000
-128,262,000
Acquisitions, net
-
0
-4,890,000
-2,958,686,000
-28,328,000
Purchases of investments
-9,968,000
-12,596,000
-7,551,000
-17,099,000
-88,657,000
Sales/maturities of investments
34,024,000
74,604,000
49,402,000
65,035,000
40,743,000
Other investing activities
-5,630,000
-10,343,000
-14,125,000
64,274,000
13,006,000
Net cash used for investing activities
261,957,000
393,530,000
292,119,000
-2,835,698,000
-93,342,000
Cash flows from financing activities
Debt repayment
-781,260,000
-1,690,976,000
-731,057,000
-1,741,000
-142,658,000
Common stock repurchased
-2,548,000
-2,141,000
-3,737,000
-1,172,000
-18,756,000
Dividends paid
-283,176,000
-283,357,000
-282,582,000
-142,952,000
-141,893,000
Other financing activities
-66,000
-35,002,000
-5,593,000
-36,229,000
-4,076,000
Net cash used provided by (used for) financing activities
-1,328,549,000
-1,088,354,000
-1,005,213,000
2,946,237,000
-326,226,000
Net change in cash
-47,661,000
316,107,000
-43,342,000
439,018,000
-41,714,000
Cash at beginning of period
630,868,000
637,614,000
702,722,000
294,973,000
341,252,000
Cash at end of period
583,408,000
966,222,000
637,614,000
702,093,000
294,522,000
Free cash flow
Operating cash flow
1,018,931,000
1,010,931,000
669,752,000
328,479,000
377,854,000
Capital expenditure
-241,359,000
-236,468,000
-217,710,000
-134,114,000
-128,262,000
Free cash flow
777,572,000
774,463,000
452,042,000
194,365,000
249,592,000